A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers
- 1 August 1992
- journal article
- Published by Elsevier BV in Journal of Vascular Surgery
- Vol. 16 (2), 251-257
- https://doi.org/10.1016/0741-5214(92)90115-o
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetateJournal of Surgical Research, 1992
- Enhancement of Wound Healing by Topical Treatment with Epidermal Growth FactorNew England Journal of Medicine, 1989
- In vitro toxicity of topical antimicrobial agents to human fibroblastsJournal of Surgical Research, 1989
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide‐copper complex glycyl‐L‐histidyl‐L‐lysine‐Cu2+FEBS Letters, 1988
- A mimic of superoxide dismutase activity based upon desferrioxamine B and manganese(IV)Archives of Biochemistry and Biophysics, 1987
- Chronic ulcer of the leg: clinical history.BMJ, 1987
- [28] Biological activity of human plasma copper-binding growth factor glycyl-l-histidyl-l-lysineMethods in enzymology, 1987
- Leg ulcers: Epidemiology and aetiologyBritish Journal of Surgery, 1986
- The complex formation of copper(II) with GHL and related peptidesInorganica Chimica Acta, 1985
- Chronic ulceration of the leg: extent of the problem and provision of care.BMJ, 1985